Abstract
Objective
Data Sources
Study Selection
Data Extraction
Data Synthesis
Conclusions
Keywords
List of abbreviations:
BoNTA (botulinum toxin type A), EMG (electromyogram), LOE (level of evidence), UMN (upper motor neuron)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationReferences
- Activity of muscle spindles during muscle twitch and clonus in normal and spastic human subjects.Electroencephalogr Clin Neurophysiol. 1974; 37: 589-597
- Clonus: definition, mechanism, treatment.Med Glas (Zenica). 2015; 12: 19-26
- Managing upper extremity clonus with intramuscular botulinum toxin-A injections in a patient poststroke.PM R. 2015; 7: 542-546
- Unstable gait due to spasticity of the rectus femoris: gait analysis and motor nerve block.Ann Phys Rehabil Med. 2012; 55: 609-622
- Patellar clonus: an autonomous central generator.J Neurol Neurosurg Psychiatry. 1987; 50: 1225-1227
- Botulinum toxin in gait dysfunction due to ankle clonus: a case series.NeuroRehabilitation. 2013; 32: 635-647
- Functional impact of ankle clonus based on patient perceptions.Arch Phys Med Rehabil. 2015; 96: e13-e14
- Spinal myoclonus complicating spasticity in spinal cord injury: a case study.Arch Phys Med Rehabil. 1997; 78: 1007-1009
- Effect of cold application and tizanidine on clonus: clinical and electrophysiological assessment.J Spinal Cord Med. 2009; 32: 132-139
- The H reflex recovery curve reinvestigated: low-intensity conditioning stimulation and nerve compression disclose differential effects of presumed group Ia fibres in man.Hum Neurobiol. 1988; 6: 281-288
- A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.Curr Med Res Opin. 1981; 7: 374-383
- Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.Neurology. 2004; 63: 1357-1363
- Botulinum toxin type A versus phenol: a clinical and neurophysiological study in the treatment of ankle clonus.Eur J Phys Rehabil Med. 2010; 46: 11-18
- Botulinum toxin: mechanisms of action.Arq Neuropsiquiatr. 2005; 63: 180-185
- Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.Neurosci Lett. 2013; 541: 20-23
- On muscle spindles, dystonia and botulinum toxin.Eur J Neurol. 2010; 17: 71-80
- Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.Arch Ital Biol. 2004; 142: 265-273
Howick J, Chalmers I, Glasziou P, et al. The 2011 Oxford Centre for Evidence-Based Medicine levels of evidence Available at: http://www.cebm.net/index.aspx?o=5653. Accessed March 28, 2016.
- Treatment strategies for genu recurvatum in adult patients with hemiparesis: a case series.PM R. 2015; 7: 105-112
- Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study.Am J Phys Med Rehabil. 2006; 85: 75-81
- Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial.Am J Phys Med Rehabil. 1998; 77: 510-515
- Botulinum toxin treatment of lumbrical spasticity: a brief report.Am J Phys Med Rehabil. 1998; 77: 348-350
- Botulinum toxin injection of spastic finger flexors in hemiplegic patients.Am J Phys Med Rehabil. 2000; 79: 44-47
- Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: a randomized double-blind controlled trial.Clin Rehabil. 2014; 28: 604-613
- Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.J Neurol Neurosurg Psychiatry. 1994; 57: 1321-1324
- Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.Stroke. 1996; 27: 455-460
- Disability changes after treatment of upper limb spasticity with botulinum toxin.Neurorehabil Neural Repair. 1996; 10: 47-52
- Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity.Eur J Neurol. 2008; 15: 506-511
- Statistical power analysis for the behavioral sciences.2nd ed. Lawrence Erlbaum Associates, Hillsdale1988
- Continuum of reflex excitability in hemiplegia: influence of muscle length and muscular transformation after heel-cord lengthening and immobilization on the pathophysiology of spasticity and clonus.Dev Med Child Neurol. 1999; 41: 534-548
- Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.Muscle Nerve. 1994; 17: 1385-1392
- Effect of topical anesthetics on needle insertion pain during botulinum toxin type A injections for limb spasticity.Arch Phys Med Rehabil. 2012; 93: 1643-1647
- Adverse clinical effects of botulinum toxin intramuscular injections for spasticity.Canad J Neurol Sci. 2016; 43: 298-310
- Possible adverse effects of repeated botulinum toxin A injections to decrease post-stroke spasticity in adults undergoing rehabilitation: a review of the literature.J Allied Health. 2015; 44: 140-144
- Revisiting physiologic and psychologic triggers that increase spasticity.Am J Phys Med Rehabil. 2013; 92: 357-369
- Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.Physiother Can. 2015; 67: 157-166
Article info
Publication history
Footnotes
Supported by the West Park Foundation.
Disclosures: C.P.P., F.I., and C.B. have received research grants from Allergan and Merz. F.I. and C.B. have received speaker fees and honoraria from Allergan and Merz.